Clay Thorp Insider Trading $PHAS PhaseBio Pharmaceuticals Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Clay Thorp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Clay Thorp. Clay Thorp is Director in PhaseBio Pharmaceuticals Inc ($PHAS) and Director in Clearside Biomedical, Inc. ($CLSD) and 10% Owner in G1 Therapeutics, Inc. ($GTHX).

Clay Thorp in PhaseBio Pharmaceuticals Inc

Trading Symbol: PHAS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clay Thorp: Director
Holdings: 1,818,638 shares
Latest Transaction: Jun 04 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Clay Thorp in PhaseBio Pharmaceuticals Inc

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLSD, GTHX, PHAS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 04 2021	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	3.53	14,000	49,420	14,000
Jun 05 2020	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	4.86	16,000	77,760	16,000
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	459	6,426	415,959	416.4 K to 416 K (-0.11 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	255	3,570	52,397	52.7 K to 52.4 K (-0.48 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	180	2,520	162,890	163.1 K to 162.9 K (-0.11 %)
Jul 03 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	2,014	28,196	1,818,638	1.8 M to 1.8 M (-0.11 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	63	882	416,418	416.5 K to 416.4 K (-0.02 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	35	490	52,655	52.7 K to 52.7 K (-0.07 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	25	350	163,074	163.1 K to 163.1 K (-0.02 %)
Jun 20 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Sell	S	14.00	277	3,878	1,820,656	1.8 M to 1.8 M (-0.02 %)
May 13 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	13.23	11,000	145,530	11,000
Mar 01 2019	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	A	3.15	36,000	113,400	36,000
Dec 06 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	3.13	4,000	12,520	15,799	11.8 K to 15.8 K (+33.90 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	226,061	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	24,709	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	272,107	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	40,420	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,558	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	149,320	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	94,874	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	1,044,764	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	13,609	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	174,699	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	4,846	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	3,862	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	42,530	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	C	0.00	52,690	0	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	994	0	40,420
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	41,414	0	41,414
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	41,414	4,970	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	104	0	13,558
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	4,309	0	13,662
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	4,309	517	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	1,139	0	149,320
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	47,458	0	150,459
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	47,458	5,695	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	42	0	94,874
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	1,731	0	94,916
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	1,731	208	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	S	0.00	458	0	1,044,764
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.00	19,061	0	1,045,222
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Option Exercise	M	0.12	19,061	2,287	0
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	150,000	750,000	416,481	266.5 K to 416.5 K (+56.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	266,481	0	266,481	0 to 266.5 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	4,846	0	4,846	0 to 4.8 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	12,487	62,435	163,099	150.6 K to 163.1 K (+8.29 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	150,612	0	150,612	0 to 150.6 K
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	P	5.00	137,513	687,565	1,820,933	1.7 M to 1.8 M (+8.17 %)
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	1,683,420	0	1,683,420	0 to 1.7 M
Oct 24 2018	PHAS	PhaseBio Pharmaceu ...	Thorp Clay	Director	Buy	C	0.00	52,690	0	52,690	0 to 52.7 K

Page: 1